{"count": 7, "results": [{"_id": "37451514", "pmid": 37451514, "title": "Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1alpha signaling pathway.", "journal": "Ann Hepatol", "authors": ["Yang J", "Li S", "Liu S", "Zhang Y", "Shen D", "Wang P", "Dang X"], "date": "2023-07-12T00:00:00Z", "doi": "10.1016/j.aohep.2023.101135", "meta_date_publication": "2023 Jul 12", "meta_volume": "", "meta_issue": "", "meta_pages": "101135", "score": 50257.082, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates @DISEASE_Liver_Cirrhosis @DISEASE_MESH:D008103 @@@liver fibrosis@@@ induced by @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@congestive hepatopathy@@@ via the @GENE_MTOR @GENE_56717 @@@mTOR@@@/@GENE_HIF1A @GENE_15251 @@@HIF-1alpha@@@ signaling pathway.", "citations": {"NLM": "Yang J, Li S, Liu S, Zhang Y, Shen D, Wang P, Dang X. Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1alpha signaling pathway. Ann Hepatol. 2023 Jul 12;():101135. PMID: 37451514", "BibTeX": "@article{37451514, title={Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1alpha signaling pathway.}, author={Yang J and Li S and Liu S and Zhang Y and Shen D and Wang P and Dang X}, journal={Ann Hepatol}, pages={101135}}"}}, {"_id": "34775423", "pmid": 34775423, "title": "Metformin Prevents Low-dose Isoproterenol-induced Cardiac Dilatation and Systolic Dysfunction in Male Sprague Dawley Rats.", "journal": "J Cardiovasc Pharmacol", "authors": ["Peterson VR", "Norton GR", "Madziva MT", "Makaula S"], "date": "2022-03-01T00:00:00Z", "doi": "10.1097/FJC.0000000000001172", "meta_date_publication": "2022 Mar 1", "meta_volume": "79", "meta_issue": "3", "meta_pages": "289-295", "score": 50253.76, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Prevents Low-dose @CHEMICAL_Isoproterenol @CHEMICAL_MESH:D007545 @@@Isoproterenol@@@-induced @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@Cardiac Dilatation@@@ and @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@Systolic Dysfunction@@@ in Male Sprague Dawley @SPECIES_10116 @@@Rats@@@.", "citations": {"NLM": "Peterson VR, Norton GR, Madziva MT, Makaula S. Metformin Prevents Low-dose Isoproterenol-induced Cardiac Dilatation and Systolic Dysfunction in Male Sprague Dawley Rats. J Cardiovasc Pharmacol. 2022 Mar 1;79(3):289-295. PMID: 34775423", "BibTeX": "@article{34775423, title={Metformin Prevents Low-dose Isoproterenol-induced Cardiac Dilatation and Systolic Dysfunction in Male Sprague Dawley Rats.}, author={Peterson VR and Norton GR and Madziva MT and Makaula S}, journal={J Cardiovasc Pharmacol}, volume={79}, number={3}, pages={289-295}}"}}, {"_id": "37060659", "pmid": 37060659, "title": "Doxorubicin downregulates autophagy to promote apoptosis-induced dilated cardiomyopathy via regulating the AMPK/mTOR pathway.", "journal": "Biomed Pharmacother", "authors": ["Zhang S", "Wei X", "Zhang H", "Wu Y", "Jing J", "Huang R", "Zhou T", "Hu J", "Wu Y", "Li Y", "You Z"], "date": "2023-06-01T00:00:00Z", "doi": "10.1016/j.biopha.2023.114691", "meta_date_publication": "2023 Jun", "meta_volume": "162", "meta_issue": "", "meta_pages": "114691", "score": 50251.848, "text_hl": "In addition, @CHEMICAL_Sirolimus @CHEMICAL_MESH:D020123 @@@rapamycin@@@ reduced oxidative stress, prevented @DISEASE_Mitochondrial_Diseases @DISEASE_MESH:D028361 @@@mitochondrial damage@@@, and restored energy metabolic homeostasis in @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@DOX@@@-treated cardiomyocytes. In vivo, we used @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@) which is an @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@ activator to protect cardiac tissue to alleviate @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@DOX@@@-induced @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@dilated cardiomyopathy@@@. ", "citations": {"NLM": "Zhang S, Wei X, Zhang H, Wu Y, Jing J, Huang R, Zhou T, Hu J, Wu Y, Li Y, You Z. Doxorubicin downregulates autophagy to promote apoptosis-induced dilated cardiomyopathy via regulating the AMPK/mTOR pathway. Biomed Pharmacother. 2023 Jun;162():114691. PMID: 37060659", "BibTeX": "@article{37060659, title={Doxorubicin downregulates autophagy to promote apoptosis-induced dilated cardiomyopathy via regulating the AMPK/mTOR pathway.}, author={Zhang S and Wei X and Zhang H and Wu Y and Jing J and Huang R and Zhou T and Hu J and Wu Y and Li Y and You Z}, journal={Biomed Pharmacother}, volume={162}, pages={114691}}"}}, {"_id": "35636318", "pmid": 35636318, "pmcid": "PMC9156889", "title": "Patient-derived microphysiological model identifies the therapeutic potential of metformin for thoracic aortic aneurysm", "journal": "EBioMedicine", "authors": ["Ma W", "Zhang J", "Liu S", "Yan S", "Xu K", "Zhang YS", "Abudupataer M", "Ming Y", "Zhu S", "Xiang B", "Zhou X", "Luo S", "Huang H", "Tang Y", "Zhang S", "Xie Z", "Chen N", "Sun X", "Li J", "Lai H", "Wang C", "Zhu K", "Zhang W"], "date": "2022-07-01T00:00:00Z", "doi": "10.1016/j.ebiom.2022.104080", "meta_date_publication": "2022 Jul", "meta_volume": "81", "meta_issue": "", "meta_pages": "104080", "score": 50243.59, "text_hl": "@SPECIES_10090 @@@Mouse@@@ @DISEASE_Aortic_Aneurysm_Thoracic @DISEASE_MESH:D017545 @@@TAA@@@ model and @SPECIES_9606 @@@human@@@ clinical data validate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may maintain contractile phenotype and delay @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@aortic dilation@@@.", "citations": {"NLM": "Ma W, Zhang J, Liu S, Yan S, Xu K, Zhang YS, Abudupataer M, Ming Y, Zhu S, Xiang B, Zhou X, Luo S, Huang H, Tang Y, Zhang S, Xie Z, Chen N, Sun X, Li J, Lai H, Wang C, Zhu K, Zhang W. Patient-derived microphysiological model identifies the therapeutic potential of metformin for thoracic aortic aneurysm EBioMedicine. 2022 Jul;81():104080. PMID: 35636318", "BibTeX": "@article{35636318, title={Patient-derived microphysiological model identifies the therapeutic potential of metformin for thoracic aortic aneurysm}, author={Ma W and Zhang J and Liu S and Yan S and Xu K and Zhang YS and Abudupataer M and Ming Y and Zhu S and Xiang B and Zhou X and Luo S and Huang H and Tang Y and Zhang S and Xie Z and Chen N and Sun X and Li J and Lai H and Wang C and Zhu K and Zhang W}, journal={EBioMedicine}, volume={81}, pages={104080}}"}}, {"_id": "30922066", "pmid": 30922066, "title": "Metformin Enhances Autophagy and Provides Cardioprotection in delta-Sarcoglycan Deficiency-Induced Dilated Cardiomyopathy.", "journal": "Circ Heart Fail", "authors": ["Kanamori H", "Naruse G", "Yoshida A", "Minatoguchi S", "Watanabe T", "Kawaguchi T", "Yamada Y", "Mikami A", "Kawasaki M", "Takemura G", "Minatoguchi S"], "date": "2019-04-01T00:00:00Z", "doi": "10.1161/CIRCHEARTFAILURE.118.005418", "meta_date_publication": "2019 Apr", "meta_volume": "12", "meta_issue": "4", "meta_pages": "e005418", "score": 50065.617, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Enhances Autophagy and Provides Cardioprotection in delta-Sarcoglycan Deficiency-Induced @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@Dilated Cardiomyopathy@@@.", "citations": {"NLM": "Kanamori H, Naruse G, Yoshida A, Minatoguchi S, Watanabe T, Kawaguchi T, Yamada Y, Mikami A, Kawasaki M, Takemura G, Minatoguchi S. Metformin Enhances Autophagy and Provides Cardioprotection in delta-Sarcoglycan Deficiency-Induced Dilated Cardiomyopathy. Circ Heart Fail. 2019 Apr;12(4):e005418. PMID: 30922066", "BibTeX": "@article{30922066, title={Metformin Enhances Autophagy and Provides Cardioprotection in delta-Sarcoglycan Deficiency-Induced Dilated Cardiomyopathy.}, author={Kanamori H and Naruse G and Yoshida A and Minatoguchi S and Watanabe T and Kawaguchi T and Yamada Y and Mikami A and Kawasaki M and Takemura G and Minatoguchi S}, journal={Circ Heart Fail}, volume={12}, number={4}, pages={e005418}}"}}, {"_id": "11835925", "pmid": 11835925, "title": "Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus.", "journal": "Am J Cardiol", "authors": ["Gaenzer H", "Neumayr G", "Marschang P", "Sturm W", "Lechleitner M", "Föger B", "Kirchmair R", "Patsch J"], "date": "2002-02-15T00:00:00Z", "doi": "10.1016/s0002-9149(01)02266-4", "meta_date_publication": "2002 Feb 15", "meta_volume": "89", "meta_issue": "4", "meta_pages": "431-4", "score": 50046.824, "text_hl": "@DISEASE_Vascular_Diseases @DISEASE_MESH:D014652 @@@Endothelial dysfunction@@@ is an early marker of @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerosis@@@ occurring in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@. @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@Endothelium-dependent dilation@@@ (@<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@EDD@@@) has been shown to improve by combined therapy of @GENE_INS @GENE_3630 @@@insulin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. ", "citations": {"NLM": "Gaenzer H, Neumayr G, Marschang P, Sturm W, Lechleitner M, Föger B, Kirchmair R, Patsch J. Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus. Am J Cardiol. 2002 Feb 15;89(4):431-4. PMID: 11835925", "BibTeX": "@article{11835925, title={Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus.}, author={Gaenzer H and Neumayr G and Marschang P and Sturm W and Lechleitner M and Föger B and Kirchmair R and Patsch J}, journal={Am J Cardiol}, volume={89}, number={4}, pages={431-4}}"}}, {"_id": "22048751", "pmid": 22048751, "title": "Metformin causes nitric oxide-mediated dilatation in a shorter time than insulin in the iliac artery of the anesthetized pig.", "journal": "J Cardiovasc Pharmacol", "authors": ["O'Hora TR", "Markos F", "Wiernsperger NF", "Noble MI"], "date": "2012-02-01T00:00:00Z", "doi": "10.1097/FJC.0b013e31823b4b94", "meta_date_publication": "2012 Feb", "meta_volume": "59", "meta_issue": "2", "meta_pages": "182-7", "score": 50045.734, "text_hl": "We tested the hypothesis that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ produces @<m>DISEASE_Cardiomyopathy_Dilated</m> @DISEASE_MESH:D002311 @@@arterial dilatation@@@ indirectly, by directly exposing the endothelial surface, of an occluded test segment of the @SPECIES_9823 @@@pig@@@ iliac artery in vivo, to test blood containing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or excess @GENE_INS @GENE_397415 @@@insulin@@@, with and without the presence of the @GENE_NOS2 @GENE_396859 @@@nitric oxide (NO) synthase@@@ inhibitor NG-nitro-L-arginine methyl ester hydrochloride. ", "citations": {"NLM": "O'Hora TR, Markos F, Wiernsperger NF, Noble MI. Metformin causes nitric oxide-mediated dilatation in a shorter time than insulin in the iliac artery of the anesthetized pig. J Cardiovasc Pharmacol. 2012 Feb;59(2):182-7. PMID: 22048751", "BibTeX": "@article{22048751, title={Metformin causes nitric oxide-mediated dilatation in a shorter time than insulin in the iliac artery of the anesthetized pig.}, author={O'Hora TR and Markos F and Wiernsperger NF and Noble MI}, journal={J Cardiovasc Pharmacol}, volume={59}, number={2}, pages={182-7}}"}}]}